MRES OTC
Institute of Biomedical Research Corp.
1W: -20.4%
1M: -56.2%
3M: +86.2%
YTD: -37.5%
1Y: -71.8%
3Y: -93.1%
5Y: -89.5%
$0.00
-0.00 (-14.63%)
Weekly Expected Move ±26.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$232K
+43.0% ▲
Capital Expenditures
$8K
-2.7% ▼
Free Cash Flow
-$239K
+42.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$0
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$177K | -$690K | -$5M | -$443K | -$273K |
| Depreciation & Amort. | $713 | $0 | $11K | $28K | $23K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$17K | $18K | -$25K | $9K | $17K |
| Other Non-Cash Items | $38K | $649K | $5M | $0 | $2K |
| Operating Cash Flow | -$155K | -$23K | -$98K | -$407K | -$232K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$107K | -$7K | -$8K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$16K |
| Investing Cash Flow | $0 | $0 | -$107K | -$7K | -$24K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $23K | $195K | $397K | $414K | $255K |
| Financing Cash Flow | $106K | $23K | $206K | $414K | $255K |
| Net Change in Cash | -$49K | $0 | $0 | $0 | $0 |
| Cash End of Period | -$4 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$155K | -$23K | -$206K | -$414K | -$239K |